BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16988508)

  • 1. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
    Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
    Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
    Tsutsui M; Koike M; Komatsu N
    Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood lipid profiles in children with acute lymphoblastic leukemia.
    Halton JM; Nazir DJ; McQueen MJ; Barr RD
    Cancer; 1998 Jul; 83(2):379-84. PubMed ID: 9669823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experience with plasma exchange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to L-asparaginase.
    Bilgir O; Calan M; Bilgir F; Cagliyan G; Arslan O
    Transfus Apher Sci; 2013 Oct; 49(2):328-30. PubMed ID: 23871581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis with L-asparaginase therapy.
    Mondal R; Nandi M; Tiwari A; Chakravorti S
    Indian Pediatr; 2011 Sep; 48(9):735-6. PubMed ID: 21992909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
    Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
    Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
    Earl M
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
    Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.